Research > ETFs > ETF / ETP Commentary > 

NTHM ETF Rotates Into Midstream Energy & GLP-1 Healthcare

The NBI Thematic Rotation ETF (NTHM:TSX) has completed its latest portfolio rebalance, pivoting away from broad tech and industrial momentum to channel capital into midstream energy infrastructure and GLP-1 weight-loss drug manufacturers. The fund tracks the Thematic Rotation Quality Momentum Screened Index.Key Takeaways Technology fell from 40.78% to 25.20%, a decline of 15.58 percentage points. Industrial Goods also dropped from 16.79% to 5.68%. Energy rose from 10.70% to 25.17%, while healthcare jumped from 0.08% to 15.42%. The new allocations added major positions in midstream energy and GLP-1 drugmakers. The NTHM ETF reduced top-10 concentration from 27.87% to 19.56%. Its seven main themes now include midstream energy, e-sports & interactive gaming, GLP-1 weight-loss drug manufacturers, semiconductors, robotic technologies & computation, battery minerals & raw materials, and natural resources. NTHM ETF Trims Tech, Adds Energy and HealthcareTechnology fell from 40.78% to 25.20%. That represents a 15.58-percentage-point decline. High-momentum names such as KLA Corp. (KLAC) and Palantir (PLTR) also moved lower in the portfolio’s rankings. Energy increased from 10.70% to 25.17%. That represents a gain of 14.47 percentage points. North American midstream operators drove much of the increase. The fund added major positions in companies such as ONEOK (OKE), Williams Companies (WMB), and Kinder Morgan (KMI). These businesses operate energy infrastructure, including pipelines and related midstream assets. Healthcare rose from just 0.08% to 15.42%. The 15.34-percentage-point increase gives the sector a much larger role in the NTHM ETF. The new exposure centers on metabolic-drug manufacturers and the GLP-1 weight-loss market. Eli Lilly (LLY) and Novo Nordisk (NVO) both entered the fund’s top 10 holdings.Industrial Goods and Materials DeclineIndustrial goods fell from 16.79% to 5.68%, a decline of 11.11 percentage points. Basic materials also declined, falling from 23.07% to 16.01%. Together, the changes show a clear shift in the NTHM ETF’s sector mix. Technology and industrial stocks now account for a much smaller share of the portfolio, while energy and healthcare have gained substantial weight. Bloom Energy (BE), KLA Corp., Showa Denko, and Albemarle dropped out of the top 10. They were replaced by energy infrastructure and pharmaceutical companies, alongside existing holdings such as Meta Platforms (META), Microsoft (MSFT), and Tencent (TCEHY). See More: National Bank Launches New NBI Thematic Rotation ETFNTHM ETF Expands Beyond U.S. StocksThe portfolio also became somewhat less U.S.-heavy. U.S. equity exposure fell from 50.17% to 43.04%, while Canadian holdings rose to 7.87%, helped by the fund’s larger allocation to North American energy infrastructure. NTHM is now spread across seven major themes, with allocations ranging from roughly 12.5% to 16%: Midstream Energy: 16.03% E-Sports & Interactive Gaming: 14.67% GLP-1 Weight-Loss Drug Manufacturers: 14.41% Semiconductors: 14.32% Robotic Technologies & Computation: 14.27% Battery Minerals & Raw Materials: 13.74% Natural Resources: 12.56% The latest rebalance highlights how quickly NTHM can shift as market themes change. The fund reduced exposure to technology and industrial stocks that had previously dominated the portfolio, while increasing allocations to energy infrastructure and healthcare. At the same time, the lower weight of the top 10 holdings leaves the portfolio more broadly distributed across its seven thematic exposures. For more news, information, and analysis, visit the ETFs in Canada Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.